肝硬化患者LI-RADS 3或4类观察与组织病理学诊断的相关性
本文关注肝硬化患者中LI-RADS 3或4类观察与组织病理学诊断的相关性,指出这类观察在接受HCC监测的患者中见于超过四分之一,进展为HCC风险高但差异大,约三分之一LR-3和超过三分之二LR-4观察发展为HCC,监测策略实践差异大,其组织病理学尚未被充分描述,本文据此将移植前6个月内CT或MRI至少1个LR-3或LR-4观察的肝移植受者的影像学表现与移植肝组织病理学进行关联分析。
要点
- 肝硬化患者为HCC高危人群,需以腹部超声和甲胎蛋白监测。
- 监测阳性者应接受多期CT或MRI诊断评估。
- LI-RADS将CT或MRI观察分为LR-1至LR-5,LR-3和LR-4为HCC中等风险。
核心结论
- 本文旨在关联肝移植受者移植前6个月内CT或MRI上至少1个LR-3或LR-4观察的影像学表现与移植肝组织病理学诊断。
研究设计与样本
- 本文为针对肝移植受者的影像学与移植肝组织病理学相关性分析,纳入移植前6个月内CT或MRI上至少有1个LR-3或LR-4观察的肝硬化患者。
主要发现
- LR-3和LR-4观察在接受HCC监测的患者中见于超过四分之一。
- 约三分之一的LR-3观察和超过三分之二的LR-4观察发展为HCC。
- LR-3和LR-4观察进展为HCC的风险高但存在差异,监测策略在临床实践中差异很大。
关键数值与推荐
- LI-RADS将高危患者CT或MRI观察分为LR-1(明确良性)至LR-5(明确HCC),LR-3和LR-4为HCC中等风险。
临床怎么用
- 肝硬化患者为HCC高危人群,需以腹部超声和甲胎蛋白进行监测。
- 监测结果阳性者应接受多期CT或MRI诊断评估。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients with cirrhosis are high risk for developing hepatocellular carcinoma (HCC) and warrant surveillance using abdominal ultrasound and α-fetoprotein.1 Those with positive surveillance results should undergo diagnostic evaluation with multiphase computed tomography (CT) or magnetic resonance imaging (MRI). The LI-RADS system is an evidence-based system to classify observations on CT or MRI in at-risk patients, ranging from LR-1 (definite benign) to LR-5 (definite HCC), with LR-3 and LR-4 observations being intermediate risk for HCC.2 LR-3 and LR-4 observations are observed on CT or MRI in more than one-fourth of patients undergoing HCC surveillance and have a high, yet variable, risk for progression to HCC.3 Approximately one-third of patients with LR-3 observations and more than two-thirds of LR-4 observations develop HCC, and surveillance strategies vary widely in practice.4,5 Variation in radiographic appearance and natural history of these observations suggests that this may be a heterogeneous group of patients; however, their histopathology has not been well described. Herein, we correlated imaging findings and explant histopathology from liver transplant recipients with at least 1 LR-3 or LR-4 observation on CT or MRI within 6 months preceding transplantation.
引用
- Dunn C, Lin B, Rich NE, et al. Correlation of LI-RADS 3 or 4 Observations with Histopathologic Diagnosis in Patients with Cirrhosis. Clin Gastroenterol Hepatol. 2022. PMID: 35307596. doi:10.1016/j.cgh.2022.03.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。